TNFRSF1A and glioma: Glioma samples with older age (≥60) or microvascular proliferation or necrosis or Chemo_status (chemotherapy status) or treatment and therapy status have higher TNFRSF1A expression compared with the corresponding samples (Figures 4D–J).